BioInvent extends license agreement with Mitsubishi Tanabe for development of ... pharmabiz.com BioInvent International AB, a research-based pharmaceutical company, has extended its 2009 license agreement with Mitsubishi Tanabe Pharma Corporation for the development of antibodies from BioInvent's n-CoDeR library. Under the terms of the ... |
